Skip to product information
1 of 1

GeneBio Systems

Recombinant human CDNF Protein(Fc Tag)

Recombinant human CDNF Protein(Fc Tag)

SKU:PDMH100259

Regular price $1,017.00 USD
Regular price Sale price $1,017.00 USD
Sale Sold out
Shipping calculated at checkout.

Size:100μg

Storage:Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Shipping:This product is provided as lyophilized powder which is shipped with ice packs.

Exp date:12 months

Category ID_II:Recombinant Proteins

Category ID_III:Cytokines

Abbreviation:CDNF

Target Synonym:Arginine rich mutated in early stage tumors like 1;ARMET L1;ARMET like protein 1;ARMET-like protein 1;ARMETL 1;CDNF;CDNF;Cerebral dopamine neurotrophic factor;Conserved dopamine neurotrophic factor

Research Areas:Neuroscience

Conjugation:

Target Species:human

Expression Host:Mammalian

Application:

Fusion tag:C-Fc

UNIProt ID:Q49AH0

Accession:Q49AH0

Background:Cerebral Dopamine Neurotrophic Factor (CDNF), also known as ARMETL1 (ARMET-like protein 1), is a secreted protein with eight conserved cysteine residues, predicting a unique protein fold and defining a new, evolutionarily conserved protein family. CDNF is a novel neurotrophic factor with strong trophic activity on dopaminergic neurons comparable to that of glial cell line-derived neurotrophic factor (GDNF). CDNF/ARMETL1 is a evolutionary conserved protein which can protect and restore the function of dopaminergic neurons in the rat model of Parkinson's disease, suggesting that CDNF might be beneficial for the treatment of Parkinson's disease. CDNF is widely expressed in neurons in several brain regions including cerebral cortex, hippocampus, substantia nigra, striatum and cerebellum. Human CDNF is glycosylated and secreted from transiently transfected cells. CDNF promotes the survival, growth, and function of dopamine-specific neurons and is expressed in brain regions that undergo cocaine-induced neuroplasticity.

Concentration:

Activity:Not validated for activity

Sequence:Met1-Leu187

Purity: > 90% as determined by reducing SDS-PAGE.

Formulation:Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol.

Reconstitution:It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.

Endotoxin:< 1.0 EU/mg of the protein as determined by the LAL method.

Calculated MW: 45.4 kDa

ObservedMW:40-50 kDa

View full details